Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
This year’s lectures will include a presentation by Richmond Pharmacology’s CEO and Founder, Jorg Taubel M.D.
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
To help to enrich and speeding up your drug development programs, join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss the latest state of the art methods...
Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.
View our latest peer-reviewed publications from a selection of our clinical trials.
Learn more about Richmond Pharmacology by viewing some of our videos.